We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
26
iShares Core S&P 500 ETF
IVV
$872B
$20.1M 0.56%
96,759
-3,596
-4% -$761K
COST icon
27
Costco
COST
$423B
$20M 0.56%
148,180
+3,671
+3% +$528K
BMY icon
28
Bristol-Myers Squibb
BMY
$132B
$19.7M 0.55%
296,250
+5,582
+2% +$368K
AMGN icon
29
Amgen
AMGN
$209B
$19.7M 0.55%
128,153
+8,201
+7% +$1.31M
QQQ icon
30
Invesco QQQ Trust
QQQ
$450B
$19.4M 0.54%
181,455
-2,083
-1% -$226K
MRK icon
31
Merck
MRK
$321B
$19.1M 0.53%
350,743
-9,781
-3% -$549K
CVX icon
32
Chevron
CVX
$383B
$18.7M 0.52%
193,960
-301
-0.2% -$31.6K
WLY icon
33
John Wiley & Sons Class A
WLY
$2.66B
$18.4M 0.51%
339,070
+325,000
+2,310% +$18.9M
KMI icon
34
Kinder Morgan
KMI
$70.5B
$18.4M 0.51%
480,054
-3,758
-0.8% -$157K
HD icon
35
Home Depot
HD
$332B
$18M 0.5%
162,028
+3,902
+2% +$437K
PG icon
36
Procter & Gamble
PG
$335B
$17.9M 0.5%
229,301
-11,137
-5% -$896K
APU
37
DELISTED
AmeriGas Partners, L.P.
APU
$17.5M 0.49%
383,600
+152,935
+66% +$7.36M
C icon
38
Citigroup
C
$222B
$17.3M 0.48%
313,516
+25,660
+9% +$1.4M
DIS icon
39
Walt Disney
DIS
$167B
$17.3M 0.48%
151,655
-15,688
-9% -$1.72M
DD icon
40
DuPont de Nemours
DD
$18.7B
$17.2M 0.48%
133,078
+9,879
+8% +$1.28M
DD
41
DELISTED
Du Pont De Nemours E I
DD
$17.1M 0.47%
280,748
+2,174
+0.8% +$146K
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$16.4M 0.46%
79,846
-334,745
-81% -$70.4M
MET icon
43
MetLife
MET
$62.5B
$16.2M 0.45%
324,625
+70,155
+28% +$3.32M
MO icon
44
Altria Group
MO
$113B
$15.4M 0.43%
315,532
-3,891
-1% -$197K
MIC
45
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$15.3M 0.43%
185,240
-36,584
-16% -$3.09M
PEP icon
46
PepsiCo
PEP
$191B
$15.1M 0.42%
162,031
-3,035
-2% -$290K
INTC icon
47
Intel
INTC
$460B
$14.9M 0.41%
489,282
-26,015
-5% -$841K
DXJ icon
48
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
$14.8M 0.41%
258,522
-24,028
-9% -$1.39M
CSCO icon
49
Cisco
CSCO
$448B
$14.7M 0.41%
536,920
-181,905
-25% -$5.22M
BA icon
50
Boeing
BA
$175B
$14.4M 0.4%
103,481
+11,165
+12% +$1.63M

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.